期刊文献+

子宫内膜癌bcl-2基因表达及其与PR、ER关系的研究 被引量:2

Expression of bcl-2 and Relationship with PR,ER in Endometrial Carcinoma
下载PDF
导出
摘要 [目的]探讨bcl 2与子宫内膜癌发生、发展的关系以及与PR、ER在致癌过程中有无内在联系。[方法]采用免疫组化SP法检测了58例子宫内膜癌组织中bcl 2及PR、ER的表达。[结果]子宫内膜癌中bcl 2的阳性表达率为56.9 % ,PR、ER的阳性表达率分别为55.2%、46.6%。bcl 2的阳性表达与组织学分级有关 ,而与其他临床病理学特征无关 ;PR的阳性表达与子宫内膜癌的临床病理特征都有关 ;ER的阳性表达只与肌层浸润深度有关。bcl 2的阳性表达与PR呈现正相关。[结论]bcl 2可能与子宫内膜癌的发生和分化特性有关 ;PR可能在子宫内膜癌的发生。 To discuss the role of bcl 2 in the pathogenesis and development of endometrial carcinoma and whether they have some relationship with progesterone receptor and estrogen receptor.bcl 2,PR and ER were examined by immunohistochemical method(SP method) in 58 specimens of endometrial carcinoma.bcl 2,PR,ER positive expression was 56.9%,55.2%,46.6% respectively in endometrial carcinoma.bcl 2 positive expression was correlated with tumor grade,but it was not correlated with other clinicopathologies of endometrial carcinoma.PR positive expression was correlated with clinical stage,tumor grade,the depth of myometrial tumor invasion.ER positive expression had correlation with the depth of myometrial tumor invasion only.bcl 2 positive expression was correlated with PR.[Conclusion]bcl 2 may be related to the genesis and classification of endometrial carcinoma.PR may play important role in the genesis, development of endometrial carcinoma.
出处 《肿瘤学杂志》 CAS 2001年第4期220-222,共3页 Journal of Chinese Oncology
关键词 子宫内膜癌 BCL-2基因 孕激素受体 雌激素受体 endometrial carcinoma gene,bcl-2 receptors,estrogen receptors,progesterone
  • 相关文献

参考文献1

  • 1李诵弦 于传鑫.实和妇产科内分泌学[M].上海:上海医科大学出版社,1997.296.

同被引文献22

  • 1赵霞,彭芝兰,魏丽慧,等.子宫内膜癌[M]//沈铿,崔恒,丰有吉,等.4版.北京:人民卫生出版社,2014:49-71.
  • 2Vance S, Yechieli R, Cogan C,et al. The prognostic significanceof age in surgically staged patients with Type D endometrialcarcinoma[J]. GynecolOncol, 2012,126(1):16-19.
  • 3Vandenput I,Trovik J, Leunen K, et ai. Evolution in endometrialcancer: evidence from an immunohistochemical study [J]. Int JGynecol Cancer, 2011,21(2):316-322.
  • 4recommendations for the use of tumor marks in breast andcolorectal cancer: clinical practice guidelines of the AmericanSociety of Clinical Oncology [J]. J Clin Oncol, 2001,19(6):1865-1878.
  • 5Burke WM, Orr J, Leitao M, et al. Endometrial cancer: a reviewand current management strategies: Part I [J]. Gynecol Oncol,2014,134(2):385-392.
  • 6Tomica D, Ramie S, Danolic D, et al. A correlation between theexpression of the estrogen receptors and progesterone receptors incancer cells and in the myometrium and prognostic factors inendometrial cancer[J]. Coll Antropol, 2014,38(1):129-134.
  • 7Kalogiannidis I,Petousis S, Bobos M, et al. HER-2/neu is anindependent prognostic factor in type I endometrialadenocarcinoma[J]. Arch Gynecol Obstet, 2014,15,Epub ahead ofprint.
  • 8Lazar E, Tudose N,Lazar DC. Prognostic significance of C-erbB2protein in endometrial cancer [J]. Rom J Morphol Embryol, 1998,44(1-4):101-107.
  • 9张迺哲,张文智,李绍连,赵会军,付琳杰,张中朝.抑凋谢基因bcl-2蛋白在大鼠实验性肝癌发病过程中的表达[J].实用肿瘤杂志,1999,14(1):11-13. 被引量:4
  • 10陈守菊,刘福川.乳腺癌ER、PR、PS2、C-erbB2、Ki-67联合检测的临床意义[J].临床和实验医学杂志,2011,10(9):653-654. 被引量:10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部